Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Houlihan Lokey (HLI) Cash & Equivalents (2016 - 2025)

Houlihan Lokey's Cash & Equivalents history spans 12 years, with the latest figure at $1.1 billion for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 32.17% year-over-year to $1.1 billion; the TTM value through Dec 2025 reached $1.1 billion, up 32.17%, while the annual FY2025 figure was $971.0 million, 34.63% up from the prior year.
  • Cash & Equivalents reached $1.1 billion in Q4 2025 per HLI's latest filing, up from $923.6 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $1.1 billion in Q4 2021 to a low of $449.7 million in Q2 2024.
  • Average Cash & Equivalents over 5 years is $730.7 million, with a median of $751.7 million recorded in 2021.
  • Peak YoY movement for Cash & Equivalents: surged 122.64% in 2021, then tumbled 48.1% in 2022.
  • A 5-year view of Cash & Equivalents shows it stood at $1.1 billion in 2021, then tumbled by 48.1% to $549.4 million in 2022, then grew by 1.11% to $555.5 million in 2023, then soared by 43.89% to $799.3 million in 2024, then surged by 32.17% to $1.1 billion in 2025.
  • Per Business Quant, the three most recent readings for HLI's Cash & Equivalents are $1.1 billion (Q4 2025), $923.6 million (Q3 2025), and $793.8 million (Q2 2025).